Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Apricus Biosciences- Inc. (APRI)

0.375 -0.002 (-0.6%)

07-13 15:59

Open:

0.385

Pre. Close:

0.377276

High:

0.385

Low:

0.36

Volume:

139,285

Market Cap:

9M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.381 - 0.383

0.383 - 0.384

Low:

0.355 - 0.357

0.357 - 0.359

Close:

0.376 - 0.38

0.38 - 0.383

Technical analysis  (as of: 2018-07-13 4:22:35 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.53     One year: 0.68

Support:

Support1: 0.26    Support2: 0.22

Resistance:

Resistance1: 0.46    Resistance2: 0.58

Pivot:

0.39

Moving Averages:

MA(5): 0.38     MA(20): 0.39

MA(100): 0.46     MA(250): 1.26

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 22.22     %D(3): 26.23

RSI:

RSI(14): 50.27

52-Week:

High: 3.34  Low: 0.25  Change(%): -64.3

Average Vol(K):

3-Month: 82526  10-Days 32916

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
APRI has closed above bottom band by 28.2%. Bollinger Bands are 91.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to APRI's normal range. The bands have been in this narrow range for 63 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-16T08:11:23-04:00
Apricus Bio has work to do before refiling U.S. marketing application for ED cream Vitaros; shares down 10% premarket

2018-04-06T07:14:53-04:00
Key events next week - healthcare

2018-03-29T02:38:12-04:00
Understanding Binary Catalysts: A Brief Guide For Biotech Investors

2018-03-27T18:51:07-04:00
Apricus Biosciences -27% on offering of stock, warrants

2018-03-02T09:10:21-05:00
Update On February Biotech Catalysts: What Happened And What's Next

2018-03-01T19:13:06-05:00
Apricus Biosciences' (APRI) CEO Rich Pascoe on Q4 2017 Results - Earnings Call Transcript

2018-03-01T16:03:33-05:00
Apricus Biosciences misses by $0.84

2018-02-20T15:20:43-05:00
3 Things In Biotech You Should Learn Today: February 19, 2018

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

23.44

Shares Float (M)

10.92

% Held by Insiders

53.40

% Held by Institutions

18.80

Shares Short (K)

1239

Shares Short Prior Month (K)

Stock Financials

EPS

-0.750

EPS Est. Current Year

-0.810

EPS Est. Next Year

0.360

EPS Est. Next Quarter

-0.160

Forward EPS

-0.624

Book Value (p.s.)

2.050

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-176.3

Return on Equity (ttm)

-390.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.261

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.70

Levered Free Cash Flow (M)

-5.51

atoplab.com

Valuation

P/E

-0.50

P/E Growth Ratio

-0.01

P/BV

0.18

P/S

P/CF

-0.91

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-10-24

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.